menu
    • menu

    Company profile for Chunghwa Chemical Synthesis & Biotech

    Chunghwa Chemical Synthesis & Biotech-PSE
    News
    CCSB accomplished an inspection of Münster, Germany.

    10 Apr 2024

    // PRESS RELEASE

    CCSB accomplished Caspofungin audit.

    25 Jan 2024

    // PRESS RELEASE

    CCSB obtained US patent for Tofacitinib Citrate

    11 Jan 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    CCSB VB RM

    Contact Supplier

    Website

    Biotech Showcase

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/0VmDGdKgI9U

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Related CompaniesRelated Companies

    About

    Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers global customers cost-effective APIs with speed, supported by our well-trained staff. As the first company in Southeast Asia to receive FDA approval for synthetic and biotech APIs, CCSB has a proven track record of commercializing Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs, all with complete DMF or COS. For years, CCSB has partnered with leading brand and generic drug companies to develop and produce APIs and advanced intermediates, focusing on specialty APIs crafted through a sophisticated fusion of fermentation and synthesis technologies in Taiwan.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Chunghwa Chemical Synthesis & BiotechTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    1 Tung-Hsing St., Shu-Lin 23850, New Taipei City
    Telephone
    Telephone
    +886 286843318
    Client Email
    Email
    tina.yang@ccsb.com.tw
    Client Website
    Website
    http://www.ccsb.com.tw/
    Linkedin
    Linkedin
    youtube
    YouTube
    https://www.youtube.com/@user-hx1ew6np2v/videos
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/chunghwa-chemical-synthesis-biotech-party-content-3002.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/chunghwa-chemical-synthesis-biotech-party-content-10307.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    CMO/CDMO Services

    read-more

      https://www.pharmacompass.com/pdf/party/content/chunghwa-chemical-synthesis-biotech-party-content-84116.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/chunghwa-chemical-synthesis-biotech-party-content-40024.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    CCSB accomplished an inspection of Münster, Germany.
    CCSB accomplished an inspection of Münster, Germany.

    10 Apr 2024

    // PRESS RELEASE

    https://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=114

    PRESS RELEASE
    10 Apr 2024
    Share Share
    CCSB accomplished Caspofungin audit.
    CCSB accomplished Caspofungin audit.

    25 Jan 2024

    // PRESS RELEASE

    https://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=113

    PRESS RELEASE
    25 Jan 2024
    Share Share
    CCSB obtained US patent for Tofacitinib Citrate
    CCSB obtained US patent for Tofacitinib Citrate

    11 Jan 2024

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=111

    PRESS RELEASE
    11 Jan 2024
    Share Share
    CCSB obtained US patent for Etelcalcetide
    CCSB obtained US patent for Etelcalcetide

    17 Jan 2023

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=110

    PRESS RELEASE
    17 Jan 2023
    Share Share
    CCSB accomplished Trandolapril audit.
    CCSB accomplished Trandolapril audit.

    12 Jan 2023

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=109

    PRESS RELEASE
    12 Jan 2023
    Share Share
    CCSB accomplished Methocarbamol remote audit.
    CCSB accomplished Methocarbamol remote audit.

    20 Dec 2022

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=108

    PRESS RELEASE
    20 Dec 2022
    Share Share

    USDMF

    read-more
    read-more

    01

    Baricitinib

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Chunghwa Chemical Synthesis & Biotech

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 36030

    Submission : 2021-08-04

    Status : Active

    Type : II

    CCSB Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Carfilzomib

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Chunghwa Chemical Synthesis & Biotech

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 31276

    Submission : 2016-12-30

    Status : Active

    Type : II

    CCSB Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Caspofungin Acetate

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Chunghwa Chemical Synthesis & Biotech

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 27585

    Submission : 2013-11-27

    Status : Active

    Type : II

    CCSB Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Dexbrompheniramine Maleate

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Chunghwa Chemical Synthesis & Biotech

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 8625

    Submission : 1990-06-28

    Status : Active

    Type : II

    CCSB Company Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Difelikefalin Acetate

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

    Chunghwa Chemical Synthesis & Biotech

    GDUFA

    DMF Review : N/A

    Rev. Date :